U.S. Blood Plasma Collection Market, By Type (Recovered Plasma and Source Plasma), Product Type (Needles and Syringes, Collection Tubes, and Others), Method (Automated Plasma Collection and Manual Plasma Collection), Application (Molecular Biology, Sample Recovery, Blood Glucose Analysis, Hematological Analysis, and Others), End User (Hospitals, Pathology Labs and Diagnostic Centers, Blood Banks, and Others) – Industry Trends and Forecast to 2031.
U.S. Blood Plasma Collection Market Analysis and Size
In the blood plasma collection market, advancements in automated collection technologies enhance efficiency, ensuring precise separation and collection of plasma components. Innovations also address challenges such as donor discomfort, promoting higher donation rates. These developments contribute to a more streamlined and effective blood plasma collection process, benefiting both donors and healthcare institutions.
Data Bridge Market Research analyses that the U.S. blood plasma collection market, which was USD 5.18 billion in 2023, is expected to reach USD 8.44 billion by 2031, and is expected to undergo a CAGR of 6.3% during the forecast period of 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
U.S. Blood Plasma Collection Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Recovered Plasma and Source Plasma), Product Type (Needles and Syringes, Collection Tubes, and Others), Method (Automated Plasma Collection and Manual Plasma Collection), Application (Molecular Biology, Sample Recovery, Blood Glucose Analysis, Hematological Analysis, and Others), End User (Hospitals, Pathology Labs and Diagnostic Centers, Blood Banks, and Others) |
|
Market Players Covered |
STRECK (U.S.), SIO2 Material Science (U.S.), Grifols (Spain), Instech Laboratories, Inc. (U.S.), CSL Plasma (Australia), Greiner Bio-One International GmbH (Austria), Cardinal Health (U.S.), Retractable Technologies, Inc. (U.S.), BD (U.S.), Bio Products Laboratory Ltd. (U.S.), Hemarus Plasma (U.S.), Liminal Biosciences, Inc. (Canada), Vitalant (U.S.), Takeda Pharmaceutical Company Limited (Japan), Octapharma AG (Switzerland), Kedrion (Italy) |
|
Market Opportunities |
|
Market Definition
Blood plasma collection involves extracting plasma, the liquid portion of blood containing proteins, from donors through a process called plasmapheresis. Donors are connected to a machine that separates plasma from other blood components, returning red blood cells and platelets to the donor. Plasma is then used for various medical treatments and therapies.
U.S. Blood Plasma Collection Market Dynamics
Drivers
- Increasing Aging Population Creates Demand
The global increase in the elderly demographic is driving up demand for plasma-derived products due to their susceptibility to illnesses necessitating such treatments. This demographic's higher incidence of diseases requiring plasma therapies underscores the growing need for blood plasma collection to meet healthcare demands and address the specific medical needs of the aging population.
- Government Initiatives for Safety and Quality of Product
Supportive regulatory frameworks ensure the safety and quality of plasma-derived products, fostering stakeholder confidence and driving market growth. Stringent regulations govern plasma collection, processing, and distribution, ensuring adherence to safety standards. This regulatory environment promotes trust among consumers and healthcare professionals, contributing to the expansion of the blood plasma collection market.
Opportunities
- Rise in Prevalence of Chronic Diseases Leads to Therapeutic Demands
The escalating incidence of chronic illnesses such as cancer, liver diseases, and neurological disorders is driving a heightened demand for blood plasma collection. With these conditions often necessitating plasma-derived therapies for treatment, the rise in prevalence underscores the critical need for an expanded and efficient blood plasma collection structure to meet the growing therapeutic demands.
- Increasing Public Health Initiatives for Plasma Donation
Public health campaigns advocating plasma donation, along with incentives such as compensation or donor rewards, stimulate greater participation. These initiatives raise awareness about the importance of plasma collection for lifesaving therapies, motivating individuals to contribute. Through incentivizing donations, communities can bolster plasma supplies, ensuring the availability of critical treatments for those in need.
Restraints/Challenges
- Limited Plasma Donors Harm Supply
The blood plasma collection market faces a significant challenge due to a limited pool of eligible donors. This scarcity results in unpredictable fluctuations in plasma supply, hindering the market's scalability. The ongoing struggle to expand the donor base poses a substantial obstacle without a straightforward solution, impacting the market's ability to meet growing demands for plasma-derived products.
- High Investment Cost by New Entrants
The high capital investment required for establishing plasma collection centers acts as a formidable barrier, restricting new entrants and impeding market growth. This financial burden encompasses infrastructure development, acquisition of specialized equipment, and the recruitment and training of personnel. Consequently, this financial barrier limits competition, constrains market expansion, and hampers the overall development of the blood plasma collection market.
This U.S. blood plasma collection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the U.S. blood plasma collection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In June 2021, Cardinal Health Nuclear & Precision Health Solutions secured FDA approval for LYMPHOSEEK Paediatric Indication, propelling company growth in the blood plasma collection market, with expanded offerings catering to pediatric patients, strengthening market demand and revenue
- In June 2021, Octapharma AG's octagam gained European and German approvals for dermatomyositis in adults, augmenting the company's presence in the blood plasma collection market, particularly in Europe and Germany. This diversification strengthens market competitiveness and revenue potential
- In May 2020, Grifols, S.A. commenced plasma collection from COVID-19 recovered patients, fueling growth in the blood plasma collection market by facilitating the development of hyperimmune globulin for potential coronavirus treatment. This initiative drives market expansion through innovative therapeutic solutions
- In April 2020, Octapharma AG established a specialized team to explore COVID-19 therapies and collaborated with plasma fractionation leaders to develop plasma-derived hyperimmune immunoglobulin therapy for COVID-19 treatment. This collaboration stimulates growth in the blood plasma collection market by fostering innovation and addressing urgent healthcare needs
U.S. Blood Plasma Collection Market Scope
The U.S. blood plasma collection market is segmented on the basis of type, product type, method, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Recovered Plasma
- Source Plasma
Product Type
- Needles and Syringes
- Collection Tubes
- Others
Method
- Automated Plasma Collection
- Manual Plasma Collection
Application
- Molecular Biology
- Sample Recovery
- Blood Glucose Analysis
- Hematological Analysis
- Others
End User
- Hospitals
- Pathology Labs and Diagnostic Centers
- Blood Banks
- Others
U.S. Blood Plasma Collection Market Regional Analysis/Insights
The U.S. blood plasma collection market is analysed and market size insights and trends are provided by country, type, product type, method, application and end user as referenced above.
The countries covered in the U.S. blood plasma collection market report is U.S.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The U.S. blood plasma collection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for U.S. blood plasma collection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the U.S. blood plasma collection market. The data is available for historic period 2016-2021.
Competitive Landscape and U.S. Blood Plasma Collection Market Share Analysis
The U.S. blood plasma collection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to U.S. blood plasma collection market.
Some of the major players operating in the U.S. blood plasma collection market are:
- STRECK (U.S.)
- SIO2 Material Science (U.S.)
- Grifols (Spain)
- Instech Laboratories, Inc. (U.S.)
- CSL Plasma (Australia)
- Greiner Bio-One International GmbH (Austria)
- Cardinal Health (U.S.)
- Retractable Technologies, Inc. (U.S.)
- BD (U.S.)
- Bio Products Laboratory Ltd. (U.S.)
- Hemarus Plasma (U.S.)
- Liminal Biosciences, Inc. (Canada)
- Vitalant (U.S.)
- Takeda Pharmaceutical Company Limited (Japan)
- Octapharma AG (Switzerland)
- Kedrion (Italy)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
